661 related articles for article (PubMed ID: 12046038)
1. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
4. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study.
Naves-Díaz M; Passlick-Deetjen J; Guinsburg A; Marelli C; Fernández-Martín JL; Rodríguez-Puyol D; Cannata-Andía JB
Nephrol Dial Transplant; 2011 Jun; 26(6):1938-47. PubMed ID: 20513773
[TBL] [Abstract][Full Text] [Related]
5. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
[TBL] [Abstract][Full Text] [Related]
6. Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.
Hakemi MS; Golbabaei M; Nassiri A; Kayedi M; Hosseini M; Atabak S; Ganji MR; Amini M; Saddadi F; Najafi I
Iran J Kidney Dis; 2010 Jan; 4(1):44-9. PubMed ID: 20081304
[TBL] [Abstract][Full Text] [Related]
7. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Tentori F; Blayney MJ; Albert JM; Gillespie BW; Kerr PG; Bommer J; Young EW; Akizawa T; Akiba T; Pisoni RL; Robinson BM; Port FK
Am J Kidney Dis; 2008 Sep; 52(3):519-30. PubMed ID: 18514987
[TBL] [Abstract][Full Text] [Related]
8. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass].
Sánchez Perales MC; García Cortés MJ; Borrego FJ; Fernández Martínez S; Borrego J; Pérez del Barrio P; Liébana A; Pérez Bañasco V
Nefrologia; 2000; 20(3):254-61. PubMed ID: 10917002
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age.
Heaf JG; Løkkegård H
J Nephrol; 1998; 11(4):203-10. PubMed ID: 9702872
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
11. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
[TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients.
Gohda T; Shou I; Fukui M; Funabiki K; Horikoshi S; Shirato I; Tomino Y
Am J Kidney Dis; 2002 Jun; 39(6):1255-60. PubMed ID: 12046039
[TBL] [Abstract][Full Text] [Related]
13. [Hypertension in hemodialysis patients in Andalucia].
García Cortés MJ; Ceballos M;
Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
[TBL] [Abstract][Full Text] [Related]
14. Influence of parathyroidectomy on mortality in hemodialysis patients: a prospective observational study.
Dussol B; Morand P; Martinat C; Lombard E; Portugal H; Brunet P; Berland Y
Ren Fail; 2007; 29(5):579-86. PubMed ID: 17654321
[TBL] [Abstract][Full Text] [Related]
15. [Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study].
Peña JM; Logroño JM; Pernaute R; Laviades C; Virto R; Vicente de Vera C
Nefrologia; 2006; 26(1):84-97. PubMed ID: 16649429
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
Markell MS; Altura BT; Sarn Y; Delano BG; Ifudu O; Friedman EA; Altura BM
ASAIO J; 1993; 39(3):M801-4. PubMed ID: 8268649
[TBL] [Abstract][Full Text] [Related]
17. Renal amyloidosis is associated with increased mortality in hemodialysis patients.
Sengul S; Arat Z; Ozdemir FN
Artif Organs; 2004 Sep; 28(9):846-52. PubMed ID: 15320948
[TBL] [Abstract][Full Text] [Related]
18. A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients.
Stack AG; Bloembergen WE
Am J Kidney Dis; 2001 Nov; 38(5):992-1000. PubMed ID: 11684552
[TBL] [Abstract][Full Text] [Related]
19. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
Melamed ML; Eustace JA; Plantinga LC; Jaar BG; Fink NE; Parekh RS; Coresh J; Yang Z; Cantor T; Powe NR
Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
[TBL] [Abstract][Full Text] [Related]
20. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
Slinin Y; Foley RN; Collins AJ
J Am Soc Nephrol; 2005 Jun; 16(6):1788-93. PubMed ID: 15814832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
